Esoprex 40 mg/vial (IV Injection)
40 mg vial: ৳ 100.30
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Beacon pharmaceuticals plc |
Also available as |
Title
Esoprex Medicine
Categories
- Heartburn Relief
- GERD Treatment
- Acid Reducer
- Ulcer Healing
Description
Esomeprazole is a proton pump inhibitor used for relieving chronic heartburn, healing erosive esophagitis, maintenance of healing of erosive esophagitis, eradication of Helicobacter pylori infection, Zollinger-Ellison Syndrome, acid-related dyspepsia, duodenal & gastric ulcers.
Indications
- Chronic Heartburn Relief
- GERD Symptoms Relief
- Erosive Esophagitis Healing
- Helicobacter pylori Eradication
- Zollinger-Ellison Syndrome Treatment
- Acid-related Dyspepsia Relief
- Duodenal & Gastric Ulcer Healing
Pharmacology
- Proton Pump Inhibition
- Gastric Acid Suppression
- Absorption
- Distribution
- Metabolism
- Excretion
- Combination Therapy with Antimicrobials
Dosage
- 20mg Once Daily for Erosive Esophagitis Healing
- 20mg Once Daily for Symptomatic GERD
- 40mg Once Daily for Helicobacter Pylori Eradication
- 20-80mg Once Daily for Zollinger-Ellison Syndrome
- 20-40mg Once Daily for Acid-related Dyspepsia
- 20mg Once Daily for Duodenal Ulcer
- IV Injection: 20mg or 40mg Once Daily for GERD with Erosive Esophagitis
Administration
- Swallow Tablet or Capsule Whole
- Oral Suspension Use
- IV Injection Preparation & Administration
Interaction
- Metabolism by CYP2C19 and CYP3A4
- Potential Interference with CYP2C19
- Gastric Acid Secretion Inhibition
- Absorption Interference with Gastric pH-dependent Drugs
- No Clinically Significant Interactions with Certain Drugs
Contraindications
- Known Hypersensitivity to Formulation
Side effects
- Headache
- Diarrhea
- Nausea
- Flatulence
- Abdominal Pain
- Constipation
- Dry Mouth
Pregnancy and lactation
- No Adequate Studies in Pregnant Women
- No Teratogenic Effects in Animal Studies
- Excretion in Milk Not Studied
- Breastfeeding Discontinuation if Essential
Precautions and warnings
- Symptomatic Response Does Not Rule Out Gastric Malignancy
- Administration Instructions
- Use of Antacids
- Applesauce Mixing Option for Difficulty in Swallowing Capsules
Special populations
- Safety and Effectiveness in Paediatric Patients Not Established
- No Differences in Safety and Efficacy between Elderly and Younger Individuals
- No Dosage Adjustment for Mild to Moderate Hepatic Insufficiency
- No Altered Pharmacokinetics in Renal Impairment
Overdose effects
- Lethal Dose Effects in Rats
- Symptomatic and Supportive Treatment Recommended in Overdose
- No Specific Antidote Known
- Extensive Protein Binding
Storage conditions
- Store at Temperature Not Exceeding 30°C
- Protect from Light and Moisture
- Keep Out of Reach of Children
Chemical structure
- Molecular Formula: C17H19N3O3S
- Chemical Structure Image
Commonly asked questions
- Uses of Esoprex 40mg/vial Injection
- Side Effects of Esoprex 40mg/vial Injection
- Pregnancy and Breastfeeding Concerns
- Onset of Action
- Quick Tips
Url
https://medex.com.bd/storage/res/g-res-433-esomeprazole-chemical-structure-Tj2Jfp1VmPkRjNXznKqC.svg
Related Brands
- Opton 40 mg (Capsule (Enteric Coated)) - beximco-pharmaceuticals-ltd
- Ema 40 mg (Capsule (Enteric Coated)) - globe-pharmaceuticals-ltd
- Ema 20 mg (Capsule (Enteric Coated)) - globe-pharmaceuticals-ltd
- Esonix 20 mg/vial (IV Injection) - incepta-pharmaceuticals-ltd
- Esogap 20 mg (Capsule (Enteric Coated)) - euro-pharma-ltd